tmem141 Antibody

What is TMEM141 and why is it studied?

TMEM141 is a transmembrane protein with a calculated molecular weight of approximately 12 kDa. While the specific function of this protein remains largely unknown, its membrane localization suggests potential roles in cellular signaling, transport, or structural organization . Researchers utilize TMEM141 antibodies to characterize its expression patterns, subcellular localization, and potential binding partners to better understand its physiological functions.

What applications are TMEM141 antibodies validated for?

TMEM141 antibodies have been validated for multiple experimental applications including Western Blot (WB), Immunofluorescence (IF), Immunohistochemistry (IHC), and Enzyme-Linked Immunosorbent Assay (ELISA) . These versatile applications enable researchers to detect TMEM141 in various experimental contexts, from protein expression analysis to spatial localization within tissues and cells.

What species reactivity has been confirmed for TMEM141 antibodies?

Most commercially available TMEM141 antibodies demonstrate confirmed reactivity with human samples . Some antibodies also show cross-reactivity with mouse and rat samples . Species reactivity varies between antibody products, so researchers should select antibodies appropriate for their experimental model systems. When working with non-validated species, preliminary testing is recommended to confirm cross-reactivity.

What is the typical subcellular localization pattern observed with TMEM141 antibodies?

Immunofluorescence studies using TMEM141 antibodies in HeLa cells have demonstrated membrane localization consistent with its designation as a transmembrane protein . Specifically, immunohistochemistry of human prostate tissue has revealed strong cytoplasmic positivity in glandular cells , suggesting potential localization to internal membrane structures in addition to the plasma membrane.

What are the recommended dilutions for different applications of TMEM141 antibodies?

Optimal dilutions vary by application and specific antibody formulation. Based on validated protocols, the following dilution ranges are recommended:

These ranges serve as starting points, and optimal dilutions may require titration for each specific experimental system to achieve optimal signal-to-noise ratios .

What is the best method for validating TMEM141 antibody specificity?

Validating TMEM141 antibody specificity should involve multiple approaches. Begin with Western blot analysis using positive control cell lines such as HeLa or MCF-7 cells, which have demonstrated detectable TMEM141 expression . The antibody should detect a band at approximately 12 kDa, consistent with the predicted molecular weight of TMEM141. Additional validation can include using TMEM141 knockdown or knockout systems to confirm signal reduction, peptide competition assays, or comparing results from multiple antibodies targeting different epitopes of TMEM141.

How should TMEM141 antibodies be stored to maintain optimal activity?

Most TMEM141 antibodies should be stored at -20°C for long-term preservation of activity . The typical formulation includes 50% glycerol as a cryoprotectant, eliminating the need for aliquoting when stored at -20°C. Repeated freeze-thaw cycles should be avoided to prevent protein denaturation and loss of antibody activity. Always follow manufacturer-specific storage recommendations, as buffer formulations may vary between products.

How can researchers troubleshoot discrepancies between observed and expected molecular weights in Western blots using TMEM141 antibodies?

While the calculated molecular weight of TMEM141 is approximately 12 kDa, observed band sizes may vary due to several factors. Post-translational modifications such as glycosylation, phosphorylation, or ubiquitination can alter migration patterns. Additionally, membrane proteins often exhibit anomalous migration due to their hydrophobic nature. If discrepancies are observed, researchers should consider:

• Running appropriate positive control samples (HeLa or MCF-7 cells) alongside experimental samples

• Using gradient gels to better resolve lower molecular weight proteins

• Employing reducing versus non-reducing conditions to account for potential disulfide bonding

• Validating results with multiple antibodies targeting different epitopes of TMEM141

What considerations are important when designing co-localization studies with TMEM141 antibodies?

When designing co-localization experiments to investigate TMEM141's relationship with other cellular components:

• Select secondary antibodies with minimal spectral overlap to avoid bleed-through

• Include appropriate controls (single-color stains, isotype controls)

• Consider using TMEM141 antibodies conjugated to different fluorophores (such as FITC, Alexa Fluor 488, or Alexa Fluor 647) for direct detection

• Use membrane markers such as Na⁺/K⁺-ATPase or organelle-specific markers like calnexin (ER) or GM130 (Golgi) to precisely determine TMEM141's subcellular distribution

• Employ super-resolution microscopy techniques for more detailed co-localization analysis when examining membrane microdomains

What approaches can be used to investigate TMEM141 protein-protein interactions?

To investigate TMEM141's potential binding partners and functional protein complexes:

• Immunoprecipitation (IP) using TMEM141 antibodies followed by mass spectrometry

• Proximity labeling approaches such as BioID or APEX2 fused to TMEM141

• Co-immunoprecipitation experiments with candidate interacting proteins

• Förster Resonance Energy Transfer (FRET) or Proximity Ligation Assays (PLA) to confirm direct interactions in situ

• Yeast two-hybrid or mammalian two-hybrid screening

When conducting these experiments, it is crucial to validate that the TMEM141 antibody does not interfere with potential protein-protein interaction domains .

How can researchers address high background issues in immunostaining experiments with TMEM141 antibodies?

High background in immunofluorescence or immunohistochemistry experiments with TMEM141 antibodies may result from several factors. To improve signal-to-noise ratio:

• Optimize blocking conditions using 3-5% BSA or normal serum from the same species as the secondary antibody

• Increase washing duration and frequency with PBS containing 0.05-0.1% Tween-20

• Titrate primary antibody concentration - try using higher dilutions (1:100-1:200)

• Reduce secondary antibody concentration or switch to more specific secondary antibodies

• Include additional blocking steps for endogenous peroxidase (for IHC) or autofluorescence (for IF)

• Consider using more specific detection systems such as tyramide signal amplification if signal intensity is low at higher dilutions

What controls should be included when using TMEM141 antibodies in critical experiments?

Robust experimental design with TMEM141 antibodies should include multiple controls:

• Positive control samples: HeLa or MCF-7 cells for Western blot and immunofluorescence; human prostate or tonsil tissues for immunohistochemistry

• Negative control samples: Cell lines or tissues with low or no TMEM141 expression

• Technical controls: Primary antibody omission, isotype controls, and peptide competition assays

• Knockdown/knockout validation: siRNA or CRISPR-mediated depletion of TMEM141 to confirm antibody specificity

• Multiple antibody validation: Use of alternative TMEM141 antibodies targeting different epitopes to confirm findings

How should researchers interpret discrepancies in results between different TMEM141 antibodies?

Discrepancies between different TMEM141 antibodies may arise from several factors:

• Epitope accessibility: Different antibodies recognize distinct regions of TMEM141 that may be differentially accessible depending on protein conformation, fixation method, or interaction partners

• Isoform specificity: Some antibodies may detect specific isoforms or splice variants of TMEM141

• Cross-reactivity: Certain antibodies may recognize homologous proteins with similar epitopes

• Post-translational modifications: Modifications near the epitope may interfere with antibody binding

When discrepancies occur, researchers should:

• Compare the immunogens used to generate each antibody

• Verify results with functional assays or complementary techniques (e.g., mRNA expression)

• Consider using antibodies targeting different regions of TMEM141 in parallel

• Validate findings with genetic approaches (overexpression, knockdown)

How can TMEM141 antibodies be utilized in studies of cellular stress responses?

Given that many transmembrane proteins play roles in cellular stress responses, TMEM141 antibodies can be employed to:

• Monitor TMEM141 expression levels and localization changes under various stress conditions (oxidative stress, ER stress, hypoxia)

• Perform time-course experiments to track dynamic changes in TMEM141 following stress induction

• Compare TMEM141 expression patterns between normal and pathological tissues

• Investigate potential co-localization with stress-responsive organelles or proteins

• Determine if post-translational modifications of TMEM141 occur during stress responses using phospho-specific or ubiquitin-specific co-staining

What considerations are important when using TMEM141 antibodies in tissue microarray analysis?

When applying TMEM141 antibodies to tissue microarray (TMA) analysis:

• Optimize staining protocols using known positive control tissues (prostate, tonsil) first

• Establish clear scoring criteria for TMEM141 positivity, considering both staining intensity and percentage of positive cells

• Include appropriate technical and biological controls in each TMA

• Consider dual-staining approaches to correlate TMEM141 expression with cell type-specific markers

• Validate key findings with orthogonal techniques such as in situ hybridization or quantitative PCR

• Account for potential heterogeneity in TMEM141 expression within tissues when interpreting results

How might TMEM141 antibodies contribute to understanding membrane protein trafficking and turnover?

TMEM141 antibodies can provide valuable insights into membrane protein dynamics through:

• Pulse-chase experiments combined with immunoprecipitation to determine TMEM141 protein half-life

• Co-localization studies with markers of protein trafficking pathways (COPII vesicles, endosomes, lysosomes)

• Live-cell imaging using membrane-impermeable antibodies to track surface-exposed TMEM141

• Correlation of TMEM141 localization with membrane microdomain markers

• Investigation of TMEM141 internalization, recycling, or degradation in response to cellular signaling events

• Analysis of post-translational modifications that might regulate TMEM141 trafficking or stability